The 2020 edition of Alzheimer’s Facts and Figures continues to remind us of the challenges that the tsunami that Alzheimer´s disease represents for society in general and healthcare systems and payers will bring.

  • In 2020, Alzheimer’s and other dementias will cost The US $305billion, but by 2050, these costs could rise as high as $1.1trillion
  • Between 2000 and 2018 deaths from heart disease have decreased 7.8% whilst in the same time frame deaths from Alzheimer’s disease have increased 146%
  • 1 in 3 American seniors die with Alzheimer’s or another dementia.  It kills more than breast cancer and prostate cancer combined

The identification of biomarkers for Alzheimer’s enables early detection of the disease and will accelerate the development of new therapies by ensuring that appropriate people are enrolled in clinical trials. With the discovery that Alzheimer’s may begin 20 years or more before the onset of symptoms, a substantial window of time has been opened to intervene in the progression of the disease. In the future, more will be understood about which therapies will be most effective at which points in the Alzheimer’s disease continuum.”

Click here for the entire report: